Clinical Trial Update: A Phase II Clinical Study of Induction Adebrelimab Combined With Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma (ESCC) [Phase 2]

View source ↗

Summary

Phase II clinical trial evaluating induction adebrelimab with chemotherapy followed by concurrent chemoradiotherapy for locally advanced unresectable esophageal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Squamous Cell Carcinoma

Drugs mentioned

• Adebrelimab (adebrelimab)
• Chemotherapy (chemotherapy)

Snippet

Sponsor: Hebei Medical University Fourth Hospital | Conditions: Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING